These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24028896)

  • 1. Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy.
    Wu X; Wu M; Zhao JX
    Nanomedicine; 2014 Feb; 10(2):297-312. PubMed ID: 24028896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional mesoporous silica nanoplatform based on silicon nanoparticles for targeted two-photon-excited fluorescence imaging-guided chemo/photodynamic synergetic therapy in vitro.
    Li S; Zhang Y; He XW; Li WY; Zhang YK
    Talanta; 2020 Mar; 209():120552. PubMed ID: 31892096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
    Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
    Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.
    Wang Z; Liu G; Zheng H; Chen X
    Biotechnol Adv; 2014; 32(4):831-43. PubMed ID: 24013011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in silica based nanoparticles for targeted cancer therapy.
    Yang Y; Yu C
    Nanomedicine; 2016 Feb; 12(2):317-32. PubMed ID: 26706409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
    Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
    Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
    Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
    Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.
    Butler KS; Durfee PN; Theron C; Ashley CE; Carnes EC; Brinker CJ
    Small; 2016 Apr; 12(16):2173-85. PubMed ID: 26780591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioengineered nanoparticles for siRNA delivery.
    Kozielski KL; Tzeng SY; Green JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):449-68. PubMed ID: 23821336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shape matters when engineering mesoporous silica-based nanomedicines.
    Hao N; Li L; Tang F
    Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silica nanoparticles: Biomedical applications and toxicity.
    Huang Y; Li P; Zhao R; Zhao L; Liu J; Peng S; Fu X; Wang X; Luo R; Wang R; Zhang Z
    Biomed Pharmacother; 2022 Jul; 151():113053. PubMed ID: 35594717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
    Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
    Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Cancer Cells with Photoactive Silica Nanoparticles.
    Borzęcka W; Trindade T; Torres T; Tomé J
    Curr Pharm Des; 2016; 22(39):6021-6038. PubMed ID: 27306094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-targeting glycol chitosan nanoparticles as a platform delivery carrier in cancer diagnosis and therapy.
    Lee SJ; Min HS; Ku SH; Son S; Kwon IC; Kim SH; Kim K
    Nanomedicine (Lond); 2014 Aug; 9(11):1697-713. PubMed ID: 25321170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles in recent photodynamic therapy applications.
    Bayir S; Barras A; Boukherroub R; Szunerits S; Raehm L; Richeter S; Durand JO
    Photochem Photobiol Sci; 2018 Nov; 17(11):1651-1674. PubMed ID: 30022180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemo-photodynamic combined gene therapy and dual-modal cancer imaging achieved by pH-responsive alginate/chitosan multilayer-modified magnetic mesoporous silica nanocomposites.
    Yang H; Chen Y; Chen Z; Geng Y; Xie X; Shen X; Li T; Li S; Wu C; Liu Y
    Biomater Sci; 2017 May; 5(5):1001-1013. PubMed ID: 28327716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External heavy-atomic construction of photosensitizer nanoparticles for enhanced in vitro photodynamic therapy of cancer.
    Zhou L; Wei S; Ge X; Zhou J; Yu B; Shen J
    J Phys Chem B; 2012 Oct; 116(42):12744-9. PubMed ID: 22984941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
    Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
    Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.